Disruption of survivin protein expression by treatment with YM155 accelerates the resolution of neutrophilic inflammation.

MLA

Fernandes, Débora de Oliveira, et al. “Disruption of Survivin Protein Expression by Treatment with YM155 Accelerates the Resolution of Neutrophilic Inflammation.” British Journal of Pharmacology, Nov. 2024, p. 1. EBSCOhost, https://doi.org/10.1111/bph.17375.

APA

Fernandes, D. de O., Machado, J. R., Beltrami, V. A., Santos, A. C. P. M. D., Queiroz, J. C. M., Vago, J. P., Soriani, F. M., Amaral, F. A., Teixeira, M. M., Felix, F. B., & Pinho, V. (2024). Disruption of survivin protein expression by treatment with YM155 accelerates the resolution of neutrophilic inflammation. British Journal of Pharmacology, 1. https://doi.org/10.1111/bph.17375

Chicago

Fernandes, Débora de Oliveira, Jessica Rayssa Machado, Vinicius Amorim Beltrami, Anna Clara Paiva Menezes Dos Santos, Junior, Celso Martins Queiroz, Juliana Priscila Vago, Frederico Marianetti Soriani, et al. 2024. “Disruption of Survivin Protein Expression by Treatment with YM155 Accelerates the Resolution of Neutrophilic Inflammation.” British Journal of Pharmacology, November, 1. doi:10.1111/bph.17375.